### ü´Å Critical Care Medicine: Fluid Resuscitation in Severe Sepsis

#### ‚úÖ True Statements
1. In severe **sepsis**, **intravenous crystalloid fluids** and **empiric antibiotics** targeting suspected pathogens are critical early interventions.  
2. **Immediate and aggressive fluid resuscitation** is the cornerstone of severe sepsis management, as delay in correction of tissue perfusion increases mortality.  
3. **Balanced solutions with low chloride content** (e.g., **lactated Ringer solution**) are preferred over unbalanced solutions (e.g., **0.9% saline**) in severe sepsis.  
4. Balanced crystalloids cause minimal disturbance in **acid-base equilibrium** and **electrolytes** and reduce the risk of **fluid-induced metabolic acidosis**.  
5. **Central venous catheters** are indicated for inadequate peripheral intravenous access or for specific needs (e.g., hemodynamic monitoring, infusing phlebitis-inducing medications), but insertion should **not delay fluid resuscitation**.  
6. **Erythrocyte transfusion** is generally unnecessary in critically ill patients unless there is **active bleeding** or **hemoglobin <7 g/dL (70 g/L)**.  
7. **Vasopressors** (first-line: **norepinephrine**) are reserved for cases where **intravenous fluid resuscitation is insufficient** to restore tissue perfusion in septic shock.  
8. **Glucocorticoids** have no role in treating **sepsis without shock**.

#### üí¨ Extra
1. Early fluid therapy corrects relative hypoperfusion seen in septic shock physiology.  
5. Peripheral access is usually sufficient initially; central venous access is not required for standard crystalloids.  
6. Restrictive transfusion strategy (<7 g/dL hemoglobin) reduces unnecessary blood product use.  
7. Vasopressors without fluids risk worsening hypoperfusion and organ failure.  

#### üè∑Ô∏è Tags
#CriticalCare #Sepsis #FluidResuscitation #Crystalloids #LactatedRinger #BalancedSolutions #Norepinephrine #BloodTransfusion

#### üìö Reference
Malbrain MLNG, Langer T, Annane D, et al. Intravenous fluid therapy in the perioperative and critical care setting: executive summary of the International Fluid Academy (IFA). *Ann Intensive Care*. 2020;10(1):64. PMID: 3449147 doi:10.1186/s13613-020-00679-3

#### üÜî Question ID
CCMCQ24032

#### üïí Last Updated
February 2025

---

#### üìñ Related Text
MKSAP 19: Critical Care Medicine ‚Äî Principles of Critical Care, Comprehensive Support of Critically Ill Patients, Intravenous Fluids and Volume Expanders in the ICU

---

### üìò Related Text Derivations

#### ‚úÖ True Statements ‚Äî Intravenous Fluids and Volume Expanders in the ICU
1. **Intravenous fluid administration** is one of the most common interventions in critical care but can cause adverse effects if administered injudiciously.  
2. Intravenous fluids should be prescribed and managed like any other **prescription drug**.  
3. **Crystalloids** consist of water with dissolved electrolytes, while **colloids** contain larger particles such as starches or proteins.  
4. Indications for fluid therapy include **resuscitation**, **replacement**, and **maintenance of intravascular volume**.  
5. The **composition, dose, and duration** of fluid therapy should be tailored to the specific therapeutic goals.  
6. Recent evidence supports the use of **balanced low-chloride solutions** (e.g., **lactated Ringer**) over **0.9% saline**, as they are associated with less metabolic acidosis and minimal electrolyte disturbance.

#### üí¨ Extra
1. Over-resuscitation can worsen outcomes by causing pulmonary edema or abdominal compartment syndrome.  
3. Crystalloids distribute quickly into the extracellular space; colloids stay longer intravascularly.  
4. Resuscitation = acute shock states, replacement = ongoing losses, maintenance = daily metabolic needs.  

#### üè∑Ô∏è Tags
#CriticalCare #IVFluids #Crystalloids #Colloids #BalancedSolutions #FluidTherapy

---

#### üóæ Supplemental Tables

<table>
  <caption><strong>Commonly Used Intravenous Fluids</strong></caption>
  <thead>
    <tr>
      <th>Formulation</th>
      <th>Solution Type</th>
      <th>Fluid Composition</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>0.9% saline</td>
      <td>Crystalloid (Unbalanced)</td>
      <td>
        Sodium 154 mEq/L<br>
        Chloride 154 mEq/L<br>
        Osmolarity 308 mOsm/L
      </td>
    </tr>
    <tr>
      <td>Lactated Ringer</td>
      <td>Crystalloid (Balanced)</td>
      <td>
        Calcium 3 mEq/L<br>
        Sodium 130 mEq/L<br>
        Potassium 4 mEq/L<br>
        Chloride 109 mEq/L<br>
        Lactate 28 mEq/L<br>
        Osmolarity 273 mOsm/L
      </td>
    </tr>
    <tr>
      <td>Plasma-Lyte</td>
      <td>Crystalloid (Balanced)</td>
      <td>
        Sodium 140 mEq/L<br>
        Potassium 5 mEq/L<br>
        Chloride 98 mEq/L<br>
        Magnesium 3 mEq/L<br>
        Acetate 27 mEq/L<br>
        Gluconate 23 mEq/L
      </td>
    </tr>
    <tr>
      <td>Hartmann</td>
      <td>Crystalloid (Balanced)</td>
      <td>
        Calcium 4 mEq/L<br>
        Sodium 131 mEq/L<br>
        Potassium 5 mEq/L<br>
        Chloride 111 mEq/L<br>
        Lactate 29 mEq/L<br>
        Magnesium 3 mEq/L<br>
        Osmolarity 279 mOsm/L
      </td>
    </tr>
    <tr>
      <td>Albumin</td>
      <td>Colloid</td>
      <td>
        Iso-oncotic (5%)<br>
        Hyper-oncotic (20% and 25%)
      </td>
    </tr>
  </tbody>
</table>

<p><em>Data from Malbrain MLNG, Langer T, Annane D, et&nbsp;al. Intravenous fluid therapy in the perioperative and critical care setting: executive summary of the International Fluid Academy (IFA). <em>Ann Intensive Care</em>. 2020;10:64. PMID: 32449147. doi:10.1186/s13613-020-00679-3.</em></p>

---

#### ‚úÖ True Statements (from Table: Commonly Used Intravenous Fluids)
1. **0.9% saline** contains **154 mEq/L sodium** and **154 mEq/L chloride**, with an **osmolarity of 308 mOsm/L**.  
2. **Lactated Ringer solution** contains **130 mEq/L sodium**, **109 mEq/L chloride**, **4 mEq/L potassium**, **3 mEq/L calcium**, and **28 mEq/L lactate**, with an **osmolarity of 273 mOsm/L**.  
3. **Plasma-Lyte** contains **140 mEq/L sodium**, **98 mEq/L chloride**, **5 mEq/L potassium**, **3 mEq/L magnesium**, **27 mEq/L acetate**, and **23 mEq/L gluconate**, with an osmolarity close to plasma.  
4. **Hartmann solution** contains **131 mEq/L sodium**, **111 mEq/L chloride**, **5 mEq/L potassium**, **4 mEq/L calcium**, **29 mEq/L lactate**, and **3 mEq/L magnesium**, with an **osmolarity of 279 mOsm/L**.  
5. **Albumin** is a **colloid** that can be administered in **iso-oncotic 5%** or **hyper-oncotic 20‚Äì25%** formulations.  

#### üí¨ Extra
1. The high chloride content of 0.9% saline can contribute to **hyperchloremic metabolic acidosis**.  
2. Lactate in lactated Ringer is metabolized to **bicarbonate**, making it more physiologic.  
3. Plasma-Lyte and Hartmann solution are designed to closely approximate **plasma electrolyte composition** and **physiologic osmolarity**.  
5. Albumin remains intravascular longer than crystalloids but is more costly and not indicated for routine resuscitation.
